{"result": {"id": "afc61184-7dc8-42c5-bc63-a41ba251dde4", "choices": [{"finish_reason": "stop", "index": 0, "logprobs": null, "message": {"content": "(\"entity\"<|>中华检验医学杂志<|>ORGANIZATION<|>A Chinese medical journal publishing research on various medical topics, including the detection of amines and their metabolites)\n##\n(\"entity\"<|>EurJ Endocrinol<|>ORGANIZATION<|>A European journal focused on endocrinology, publishing studies like the sensitivity of unenhanced CT imaging to exclude pheochromocytoma)\n##\n(\"entity\"<|>中华内分泌代谢杂志<|>ORGANIZATION<|>A Chinese journal specializing in endocrinology and metabolism, featuring research on pheochromocytoma and paraganglioma)\n##\n(\"entity\"<|>Endocrinology<|>ORGANIZATION<|>A journal publishing research on endocrine-related topics, including metastatic pheochromocytoma)\n##\n(\"entity\"<|>N EnglJ Med<|>ORGANIZATION<|>A prestigious medical journal covering a wide range of medical topics, including pheochromocytoma and paraganglioma)\n##\n(\"entity\"<|>European Society of Endocrinology<|>ORGANIZATION<|>A professional organization providing clinical practice guidelines for long-term follow-up of patients operated on for pheochromocytoma or paraganglioma)\n##\n(\"entity\"<|>BestPractRes ClinEndocrinolMetab<|>ORGANIZATION<|>A journal focusing on best practices in clinical endocrinology and metabolism, including hypertension in Cushing's syndrome)\n##\n(\"entity\"<|>Front Pediatr<|>ORGANIZATION<|>A journal publishing pediatric research, including studies on reninoma and monogenic forms of hypertension)\n##\n(\"entity\"<|>EndocrRev<|>ORGANIZATION<|>A review journal in endocrinology, covering topics like systemic complications of acromegaly)\n##\n(\"entity\"<|>Gland Surg<|>ORGANIZATION<|>A journal focusing on gland surgery, including research on primary hyperparathyroidism and hypertension)\n##\n(\"entity\"<|>中华心血管病杂志<|>ORGANIZATION<|>A Chinese journal specializing in cardiovascular diseases, publishing guidelines on genetic diagnosis of monogenic cardiovascular diseases)\n##\n(\"entity\"<|>J Hypertens<|>ORGANIZATION<|>A journal dedicated to hypertension research, including studies on Mendelian forms of low-renin hypertension)\n##\n(\"entity\"<|>J Clin Med<|>ORGANIZATION<|>A journal covering clinical medicine, including studies on hypertension and endothelial dysfunction in rheumatic autoimmune diseases)\n##\n(\"entity\"<|>Biomed Res Int<|>ORGANIZATION<|>A journal publishing biomedical research, including studies on cardiovascular involvement in autoimmune diseases)\n##\n(\"entity\"<|>IntJ Mol Sci<|>ORGANIZATION<|>A journal focusing on molecular sciences, including recent advances in molecular analysis for polycythaemia vera)\n##\n(\"entity\"<|>TherClinRisk Manag<|>ORGANIZATION<|>A journal on therapeutic and clinical risk management, including updates on treatment options for polycythemia vera)\n##\n(\"entity\"<|>BMCCancer<|>ORGANIZATION<|>A journal publishing cancer research, including studies on metabolic syndrome components in multiple myeloma)\n##\n(\"entity\"<|>BuitenwerfE<|>PERSON<|>A researcher involved in a multicenter study on the sensitivity of unenhanced CT imaging to exclude pheochromocytoma)\n##\n(\"entity\"<|>卢琳<|>PERSON<|>A researcher contributing to studies on new advances in pheochromocytoma and paraganglioma)\n##\n(\"entity\"<|>YoungWF<|>PERSON<|>A researcher studying metastatic pheochromocytoma and its cure)\n##\n(\"entity\"<|>Neumann HPH<|>PERSON<|>A researcher involved in studies on pheochromocytoma and paraganglioma)\n##\n(\"entity\"<|>Plouin PF<|>PERSON<|>A researcher contributing to clinical practice guidelines for long-term follow-up of patients operated on for pheochromocytoma or paraganglioma)\n##\n(\"entity\"<|>Magiakou MA<|>PERSON<|>A researcher studying hypertension in Cushing's syndrome)\n##\n(\"entity\"<|>TrnkaP<|>PERSON<|>A researcher involved in studies on reninoma as a cause of renin-mediated hypertension)\n##\n(\"entity\"<|>Gadelha MR<|>PERSON<|>A researcher studying systemic complications of acromegaly)\n##\n(\"entity\"<|>FisherSB<|>PERSON<|>A researcher involved in studies on primary hyperparathyroidism and hypertension)\n##\n(\"entity\"<|>RainaR<|>PERSON<|>A researcher contributing to studies on monogenic or Mendelian forms of hypertension)\n##\n(\"entity\"<|>LiuK<|>PERSON<|>A researcher analyzing genes involved in Mendelian forms of low-renin hypertension in Chinese early-onset hypertensive patients)\n##\n(\"entity\"<|>MahdyA<|>PERSON<|>A researcher involved in a pilot study on hypertension, endothelial dysfunction, and retinal microvasculature in rheumatic autoimmune diseases)\n##\n(\"entity\"<|>HedarAM<|>PERSON<|>A researcher studying autoimmune rheumatic diseases and vascular function)\n##\n(\"entity\"<|>Amaya-AmayaJ<|>PERSON<|>A researcher investigating cardiovascular involvement in autoimmune diseases)\n##\n(\"entity\"<|>StuckeyR<|>PERSON<|>A researcher involved in recent advances in molecular analysis for polycythaemia vera)\n##\n(\"entity\"<|>Benevolo G<|>PERSON<|>A researcher updating on emerging treatment options for polycythemia vera)\n##\n(\"entity\"<|>MarkusE<|>PERSON<|>A researcher studying components of metabolic syndrome in patients with multiple myeloma)\n##\n(\"relationship\"<|>BuitenwerfE<|>EurJ Endocrinol<|>BuitenwerfE published a study in EurJ Endocrinol<|>5)\n##\n(\"relationship\"<|>卢琳<|>中华内分泌代谢杂志<|>卢琳 published research in 中华内分泌代谢杂志<|>5)\n##\n(\"relationship\"<|>YoungWF<|>Endocrinology<|>YoungWF published a study in Endocrinology<|>5)\n##\n(\"relationship\"<|>Neumann HPH<|>N EnglJ Med<|>Neumann HPH published a study in N EnglJ Med<|>5)\n##\n(\"relationship\"<|>Plouin PF<|>European Society of Endocrinology<|>Plouin PF contributed to guidelines by the European Society of Endocrinology<|>5)\n##\n(\"relationship\"<|>Magiakou MA<|>BestPractRes ClinEndocrinolMetab<|>Magiakou MA published research in BestPractRes ClinEndocrinolMetab<|>5)\n##\n(\"relationship\"<|>TrnkaP<|>Front Pediatr<|>TrnkaP published a study in Front Pediatr<|>5)\n##\n(\"relationship\"<|>Gadelha MR<|>EndocrRev<|>Gadelha MR published research in EndocrRev<|>5)\n##\n(\"relationship\"<|>FisherSB<|>Gland Surg<|>FisherSB published a study in Gland Surg<|>5)\n##\n(\"relationship\"<|>RainaR<|>Front Pediatr<|>RainaR published research in Front Pediatr<|>5)\n##\n(\"relationship\"<|>LiuK<|>J Hypertens<|>LiuK published a study in J Hypertens<|>5)\n##\n(\"relationship\"<|>MahdyA<|>J Clin Med<|>MahdyA published research in J Clin Med<|>5)\n##\n(\"relationship\"<|>HedarAM<|>J Clin Med<|>HedarAM published a study in J Clin Med<|>5)\n##\n(\"relationship\"<|>Amaya-AmayaJ<|>Biomed Res Int<|>Amaya-AmayaJ published research in Biomed Res Int<|>5)\n##\n(\"relationship\"<|>StuckeyR<|>IntJ Mol Sci<|>StuckeyR published a study in IntJ Mol Sci<|>5)\n##\n(\"relationship\"<|>Benevolo G<|>TherClinRisk Manag<|>Benevolo G published research in TherClinRisk Manag<|>5)\n##\n(\"relationship\"<|>MarkusE<|>BMCCancer<|>MarkusE published a study in BMCCancer<|>5)\n<|COMPLETE|>", "refusal": null, "role": "assistant", "annotations": null, "audio": null, "function_call": null, "tool_calls": null}}], "created": 1751559068, "model": "deepseek-chat", "object": "chat.completion", "service_tier": null, "system_fingerprint": "fp_8802369eaa_prod0623_fp8_kvcache", "usage": {"completion_tokens": 1884, "prompt_tokens": 2836, "total_tokens": 4720, "completion_tokens_details": null, "prompt_tokens_details": {"audio_tokens": null, "cached_tokens": 1792}, "prompt_cache_hit_tokens": 1792, "prompt_cache_miss_tokens": 1044}}, "input": {"messages": [{"content": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: ��胺及其代谢物的检测现状及标 准化期望[J]. 中华检验医学杂志 ,2020,43(3) :322-327.\n[728]  BuitenwerfE, Korteweg T, Visser A, et al.  Unenhanced CT imaging is highly sensitive to exclude pheochromocytoma:  a multicenterstudy[J]. EurJ Endocrinol,2018,178(5) :431-437.\n[729]  卢琳 ,陈适 , 曾正陪.  嗜铬细胞瘤和副神经节瘤研究新进展[J]. 中华内分泌代谢杂志 ,2018,34(6) :532-536.\n[730]  YoungWF.  Metastatic pheochromocytoma: in search ofa cure [J]. Endocrinology,2020,161(3) :bqz019.\n[731]  Neumann HPH, YoungWFJr, EngC.  Pheochromocytomaand paraganglioma[J]. N EnglJ Med,2019,381(6) :552-565.\n[732]  Plouin PF, AmarL, Dekkers OM, etal.  European Society of Endocrinology clinicalpractice guideline forlong-term follow-up ofpatientsoperated on fora phaeochromocytomaora paragan- glioma[J]. EurJ Endocrinol,2016,174(5) :G1-G10.\n[733]  Magiakou MA,  SmyrnakiP,  Chrousos GP.   Hypertension in Cushing'ssyndrome[J]. BestPractRes ClinEndocrinolMetab,  2006,20(3) :467-482.\n[734]  TrnkaP, Orellana L, Walsh M, et al.  Reninoma: an uncom- mon cause of renin-mediated hypertension[J]. Front Pediatr,\n\n\n\n2014,2:89.\n[735]  Gadelha MR, KasukiL, Lim D, etal.  Systemic complications of acromegaly and the impact of the current treatment land- scape: an update[J]. EndocrRev,2019,40(1) :268-332.\n[736]  FisherSB, PerrierND.  Primaryhyperparathyroidism and hyperten- sion[J]. Gland Surg,2020,9(1) :142-149.\n[737]  RainaR, Krishnappa V, Das A, etal.  Overview ofmonogenic orMendelian forms ofhypertension[J]. FrontPediatr, 2019, 7:  263.\n[738]  中华医学会心血管病学分会精准心血管病学学组 , 中国医疗保 健国际交流促进会精准心血管病分会 , 中华心血管病杂志编辑 委员会.  单基因遗传性心血管疾病基因诊断指南[J]. 中华心血 管病杂志 ,2019,47(3) :175-196.\n[739]  LiuK, Qin F, Sun X, etal.  Analysis ofthe genes involved in Mendelian forms oflow-renin hypertension in Chinese early-on- sethypertensivepatients[J]. J Hypertens,2018,36(3) :502-509.\n[740]  MahdyA, StradnerM, RoesslerA, etal. A pilotstudy: hyper- tension, endothelialdysfunction and retinalmicrovasculature in rheumaticautoimmunediseases[J]. J Clin Med, 2021, 10(18) :  4067.\n[741]  HedarAM, StradnerMH, RoesslerA, etal. Autoimmunerheu- maticdiseasesand vascularfunction: theconceptofautoimmune atherosclerosis[J]. J Clin Med,2021,10(19) :4427.\n[742]  Amaya-AmayaJ, Montoya-SánchezL, Rojas-VillarragaA.  Cardio- vascularinvolvement in autoimmune diseases[J]. Biomed Res Int,2014,2014:367359.\n[743]  StuckeyR, Gómez-CasaresMT.  Recentadvances in the use of molecularanalysesto inform the diagnosis and prognosis ofpa- tientswithpolycythaemiavera[J]. IntJ Mol Sci, 2021, 22(9) :  5042.\n[744]  Benevolo G, Vassallo F, Urbino I, et al.  Polycythemia vera (PV) : updateonemergingtreatmentoptions[J]. TherClinRisk Manag,2021,17:209-221.\n[745]  MarkusE, TrestmanS, Cohen Y, etal. Componentsofmeta- bolic syndrome in patients with multiple myeloma and smolde- ring multiplemyeloma[J]. BMCCancer,2020,20(1) :489.\n[746]  Gavriatopoul\n######################\nOutput:", "role": "user"}], "parameters": {"model": "deepseek-chat", "frequency_penalty": 0.0, "max_tokens": 4000, "n": 1, "presence_penalty": 0.0, "temperature": 0.0, "top_p": 1.0}}, "key": "chat_6d73de17b296ce34539d639acd1f510f563e850201aee15670c627e2eb45c2c7_v2"}